Skip to content

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.

Open, Randomized, Controlled Clinical Trial of Lornoxicam as Compared to Diclofenac in Osteoarthritis of Knee Joint in Patients of Tertiary Care Hospital of Gujarat.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01055470
Enrollment
40
Registered
2010-01-25
Start date
2008-12-31
Completion date
2009-06-30
Last updated
2010-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of Knee Joint

Brief summary

The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.

Interventions

DRUGDiclofenac

Tab. Diclofenac 50 mg 12 hrly, orally, in morning and in evening after taking food for 3 months.

Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.

Sponsors

Government Medical College, Bhavnagar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed patient aged between 25 to 65 yrs of either gender suffering from osteoarthritis of knee according to criteria given by American College of Rheumatology * Informed consent obtained from the patient.

Exclusion criteria

* Patients with any other systemic llness, * Patients with pregnancy and lactation, * Patients taking other drugs like lithium\[4\], digoxin, methotrexate, anticoagulants, antidiabetics, diuretics, * Patients with H/O hypersensitivity to NSAIDs, * Patients who had consumed any analgesics in last 1 month

Design outcomes

Primary

MeasureTime frame
Difference in reduction in reading of Wong Baker face pain scale and in time of 100 meters walking test3 months

Secondary

MeasureTime frame
To monitor side effects of study drugs.3 months

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026